Tele: 561.316.3330
Breaking Medical Device News

Sunday, October 17, 2021
HomeEXECUTIVESChris Wolff Is Appointed VP of U.S. Sales at BioVentrix - Offers...

Chris Wolff Is Appointed VP of U.S. Sales at BioVentrix – Offers 20 Plus Years of Cardiac Industry Experience

October 5, 2020

Chris Wolff, a cardiac device veteran, has been appointed Vice President of U.S. Sales for BioVentrix.

Chris Wolff will be responsible for driving enrollment in the ongoing ALIVE Trial studying the Company’s Revivent TC™ Transcatheter Ventricular Enhancement System, which has reimbursement from the Centers for Medicare and Medicaid Services (CMS).

Mr. Wolff brings over 20 years of experience in sales, strategy, clinical training, and business development in medical device companies specializing in cardiac devices. Most recently, he served as the Senior National Director of Sales for the Medtronic Inc. (MDT) Mechanical Circulatory Support (MCS) business, where he successfully led commercialization efforts for the HeartWare™ HVAD™ System in the U.S. Prior to Medtronic’s $1.1 billion acquisition of the company in 2016, he served in senior sales positions for HeartWare International, Inc. (HTWR) for four years, where he achieved significant revenue growth that was instrumental to the deal.

“We are thrilled for Chris to join our already high-caliber senior management team at an exciting time for the company as we continue to develop the Revivent TC therapy in the U.S. market,” said Kenneth Miller, President and Chief Executive Officer of BioVentrix, Inc. “His proven track record of spurring adoption for innovative cardiac devices will be invaluable as we focus on completing enrollment in our U.S. pivotal trial.”

Mr. Wolff stated, “Heart failure is a debilitating disease, and more innovative interventions are needed to help manage patients along the continuum of care. I am excited to be joining a company that is pioneering the only less-invasive therapy option to treat left ventricular dysfunction caused by a heart attack for congestive heart failure patients. I look forward to working with the BioVentrix team to drive procedural growth and bring this life-saving technology to patients in need.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy